As a result of pressure from the United States, the Board agreed to appoint an Inspector General. The role of the office of the inspector general will be to assess whether the Global Fund and its grant recipients are using the money in the ways intended. Inspections, both announced and unannounced, will be conducted of the Global Fund, PRs, Sub-Recipients,…
Quality Assurance of Limited Source Pharmaceutical Products
At its October 2002 meeting, the board decided that if a medicinal product is to be eligible for purchase using Global Fund grants, it must meet various requirements. One of these is that if it is a “single- or limited-source product,” it must (a) have been found to be acceptable by the WHO-initiated UN Pilot Procurement Quality and Sourcing Project,…
Committee Restructuring
Bernard Rivers
CCM Authority over PRs
Bernard Rivers
New Chair and Vice-Chair
Bernard Rivers
NGOS CHOOSE NEW GLOBAL FUND BOARD MEMBERS
Bernard Rivers
SUCCESSES AND FAILURES AMONG GRANTS REVIEWED FOR PHASE 2
During the past month, the Global Fund Secretariat has presented 26 grants to the board for consideration for Phase 2 renewal. For each of these grants, the Fund has provided the board with the results of an extensive and candid review of the grant’s performance thus far. The Secretarit’s review of each grant is contained in two overlapping documents. First…
ROUND 5 TO COMMENCE SOON
Bernard Rivers
ITALY HAS DEALT A DOUBLE BLOW TO THE GLOBAL FUND
Bernard Rivers